1. Home
  2. AMST vs APVO Comparison

AMST vs APVO Comparison

Compare AMST & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • APVO
  • Stock Information
  • Founded
  • AMST 2017
  • APVO 2016
  • Country
  • AMST United States
  • APVO United States
  • Employees
  • AMST N/A
  • APVO N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMST Technology
  • APVO Health Care
  • Exchange
  • AMST Nasdaq
  • APVO Nasdaq
  • Market Cap
  • AMST 7.4M
  • APVO 6.5M
  • IPO Year
  • AMST 2020
  • APVO N/A
  • Fundamental
  • Price
  • AMST $3.18
  • APVO $4.18
  • Analyst Decision
  • AMST
  • APVO Strong Buy
  • Analyst Count
  • AMST 0
  • APVO 1
  • Target Price
  • AMST N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • AMST 108.3K
  • APVO 47.2K
  • Earning Date
  • AMST 02-18-2025
  • APVO 03-04-2025
  • Dividend Yield
  • AMST N/A
  • APVO N/A
  • EPS Growth
  • AMST N/A
  • APVO N/A
  • EPS
  • AMST N/A
  • APVO N/A
  • Revenue
  • AMST $114,798.00
  • APVO N/A
  • Revenue This Year
  • AMST N/A
  • APVO N/A
  • Revenue Next Year
  • AMST N/A
  • APVO N/A
  • P/E Ratio
  • AMST N/A
  • APVO N/A
  • Revenue Growth
  • AMST N/A
  • APVO N/A
  • 52 Week Low
  • AMST $1.85
  • APVO $3.65
  • 52 Week High
  • AMST $6.27
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • AMST 44.21
  • APVO 39.61
  • Support Level
  • AMST $3.15
  • APVO $3.77
  • Resistance Level
  • AMST $3.74
  • APVO $4.47
  • Average True Range (ATR)
  • AMST 0.21
  • APVO 0.29
  • MACD
  • AMST -0.00
  • APVO 0.08
  • Stochastic Oscillator
  • AMST 24.62
  • APVO 38.40

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: